Company Name: Biocept, Inc.
Biocept, Inc. develops molecular oncology diagnostics. The company’s liquid biopsies are designed to provide physicians with the information that they need through a simple blood test. The company has assays for breast cancer, colorectal cancer, gastric cancer and lung cancer as well as melanoma and intends to introduce assays for prostate cancer and other solid tumors.
Ticker Symbol: BIOC (NASDAQ)
Company Website: http://biocept.com
Headquarters: San Diego, California